Complementary Healthcare Analysis - 2019-09-16
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
| Top Gainers | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Mallinckrodt plc (MNK) | 276.54M | 3.30 | 10.37% | 17,253,832 | |
| Palatin Technologies, Inc. (PTN) | 215.60M | 1.06 | 6.00% | 2,751,918 | |
| Immunomedics, Inc. (IMMU) | 3.02B | 16.72 | 6.36% | 2,486,564 | |
| Novavax, Inc. (NVAX) | 136.58M | 6.32 | 10.68% | 1,237,695 | |
| Sesen Bio, Inc. (SESN) | 108.90M | 1.13 | 5.12% | 911,964 | |
| Top Losers | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Ritter Pharmaceuticals, Inc. (RTTR) | 10.20M | 0.32 | -70.00% | 7,289,574 | |
| PDL BioPharma, Inc. (PDLI) | 270.70M | 2.24 | -5.49% | 5,767,585 | |
| Clovis Oncology, Inc. (CLVS) | 312.10M | 5.41 | -5.25% | 3,102,070 | |
| Ardelyx, Inc. (ARDX) | 394.37M | 5.31 | -15.45% | 3,097,327 | |
| Dynavax Technologies Corporation (DVAX) | 308.81M | 4.46 | -5.91% | 1,526,674 | |
| High volume stocks reaching new highs | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Lannett Company, Inc. (LCI) | 561.21M | 13.95 | 0.43% | 4,316,441 | |
| Celgene Corporation (CELG) | 69.90B | 98.40 | -0.23% | 3,944,681 | |
| Radius Health, Inc. (RDUS) | 1.31B | 28.34 | -0.60% | 908,126 | |
| Medpace Holdings, Inc. (MEDP) | 2.94B | 85.65 | 4.55% | 474,421 | |
| High volume stocks reaching new lows | |||||
| Company | Market Cap | Price | Change% | Volume | |
| Ritter Pharmaceuticals, Inc. (RTTR) | 10.20M | 0.32 | -70.00% | 7,289,574 | |
| PDL BioPharma, Inc. (PDLI) | 270.70M | 2.24 | -5.49% | 5,767,585 | |
| Titan Pharmaceuticals, Inc. (TTNP) | 6.30M | 0.36 | -10.31% | 469,739 | |
| Major Analyst Upgrades | |||||
| Company | Current Rating | New Rating | Analyst | Current Price | Target Price |
| Aimmune Therapeutics (AIMT) | Positive | Stifel Nicolaus | $24.67 | ||
| Esperion Therapeutics (ESPR) | Sell | Neutral | Goldman Sachs Group | $36.56 | $45.00 |
| Horizon Discovery Group (HZD) | Add | Peel Hunt | GBX 140.42 | ||
| Spire Healthcare Group (SPI) | Add | Peel Hunt | GBX 124.80 | ||
| Major Analyst Downgrades | |||||
| Company | Current Rating | New Rating | Analyst | Current Price | Target Price |
| Atara Biotherapeutics (ATRA) | Buy | Hold | Jefferies Financial Group | $15.16 | $15.00 |
| Fibrocell Science (FCSC) | Buy | Hold | Canaccord Genuity | $2.92 | |
| Major Insider Buys | |||||
| Company | Insider Name | Insider Title | Price | Qty | Value |
| Bausch Health Companies Inc. (BHC) | Papa Joseph C | COB, CEO | $23.31 | 30000 | +$699,300 |
| Organogenesis Holdings Inc. (ORGO) | Avista Capital Managing Member Iv, LLC | Dir, 10% | $5.99 | 860900 | +$5,155,772 |
| Sarepta Therapeutics, Inc. (SRPT) | Barry Richard | Dir | $87.49 | 5000 | +$437,455 |
| Major Insider Sells | |||||
| Company | Insider Name | Insider Title | Price | Qty | Value |
| Alkermes Plc. (ALKS) | Pops Richard F | Dir, CEO, Alkermes plc | $22.68 | -100000 | -$2,268,220 |
| Amicus Therapeutics, Inc. (FOLD) | Crowley John F | COB, CEO | $10.05 | -20000 | -$201,030 |
| Biohaven Pharmaceutical Holding Co Ltd. (BHVN) | Aguiar Eric | Dir | $45.00 | -10000 | -$450,000 |
| Cumberland Pharmaceuticals Inc (CPIX) | Bernard Gordon R | Dir | $5.16 | -9446 | -$48,716 |
| Deciphera Pharmaceuticals, Inc. (DCPH) | Kelly Thomas Patrick | CFO | $34.97 | -11250 | -$393,440 |
| Taylor Michael Douglas | Dir | $34.97 | -22500 | -$786,832 | |
| Eagle Pharmaceuticals, Inc. (EGRX) | Hudson Executive Capital LP | Dir | $60.06 | -1312 | -$78,799 |
| Edesa Biotech, Inc. (EDSA) | Oakes Frank R. | Dir | $5.72 | -1809 | -$10,345 |
| Global Blood Therapeutics, Inc. (GBT) | Calhoun Lesley Ann | $54.36 | -2765 | -$150,296 | |
| Horizon Therapeutics Public Ltd Co (HZNP) | Konstantinovsky Irina | EVP, Chief HR Off | $26.70 | -17838 | -$476,275 |
| Shannon James Samuel | Dir | $26.44 | -25000 | -$660,936 | |
| Onconova Therapeutics, Inc. (ONTX) | Tyndall Capital Partners L P | 10% | $2.75 | -1247 | -$3,432 |
Index Watch
NASDAQ Health CareINDEXNASDAQ: IXHC
iShares NASDAQ Biotechnology Index
NASDAQ: IBB
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.